“showed a trend”

Notably, cortisol levels were lower in past suicide attempters with no recent SI or intent (i.e., over the past year) whereas those in a recent crisis only showed a trend toward lower cortisol than controls.

Feature importance analysis using a Random Forest classifier estimated five symptoms associated with Cluster 4, which showed a trend toward symptom worsening during the post‐dosing follow‐up period, and revealed that insomnia‐related HAM‐D17 items were the primary drivers of cluster separation.

Patients taking ≥ 5 to < 9 medications showed a trend toward a higher likelihood of experiencing a UMD at admission, whereas patients taking ≥ 10 medications were substantially more likely to experience a UMD.

While progression to a worse sarcopenia state showed a trend towards higher T2DM risk, this association was not statistically significant.

In our study, both the innate immune signaling and adaptive immune signaling pathways; in particular, the immune checkpoints, lysis cell activity, T cell activation, and type I IFN response pathway showed a trend of diminished activation in the high-risk group.

A complementary study by the same group ( 19 ) found that men receiving androgen deprivation therapy showed a trend toward lower leakage risk (OR: 0.70), though this was not statistically significant.

Serial hemoglobin monitoring showed a trend: 118 g/L on day 2 and 115 g/L on day 3 of admission. 2.2.2.

Analysis of the subgroup of patients with heightened symptom severity at baseline showed a trend towards higher improvement in the INKA compared to the control group.

solanacearum did not rebound as expected; instead, it showed a trend of continued suppression.

Differential analysis showed a trend toward increased infiltration of M1-like macrophages, activated CD4 memory T cells, memory B cells, and resting CD4 memory T cells, while M0-like macrophage infiltration was significantly decreased ( Figure 4b ).

In contrast, cluster 6 showed a trend of “increase from 0d to 7d and decrease from 7d to 28d”, reflecting a dynamic balance between metabolic activation in the early cultivation stage and metabolic inhibition in the later stage.

At the phylum level, Bacteroidetes showed a trend of enrichment in the treatment group.

Circulating sCD163 concentration was negatively correlated with LVEF ( p = .01) and showed a trend towards a negative correlation with NT‐proBNP, indicating that higher sCD163 levels are associated with more severe systolic dysfunction (Figure 1C,D ).

In phase 2 trials, no benefit overall was observed in cognition, although exploratory analyses showed a trend toward improvement in patients with low CSF p-tau217, defined by the median cutoff.

Chronic kidney disease showed a trend toward a longer stay, but this was not statistically significant (median 5 days vs 1.5 days, p = 0.071).

hsCRP values showed a trend favoring vericiguat treatment. hsCRP mean values decreased from 2.90 mg/L at baseline to 2.33 mg/L at 12 weeks in the vericiguat group and increased from 2.93 pm/L at baseline to 4.22 mg/L at 12 weeks in the placebo group ( Table 2 , Supplementary Figure 1 ).

Pooled analysis showed a trend toward increased risk in the corticosteroid group compared with control, although this did not reach statistical significance (RR 1.30; 95% CI: 0.80–2.11; I 2 = 0%).

For mandibular range of motion (ROM), the overall repeated-measures model demonstrated a significant main effect of time (GEE p = 0.008), while the group effect was not significant ( p = 0.554) and the Group×Time interaction showed a trend but did not reach statistical significance ( p = 0.070).

Except osteosarcoma, high GPC2 expression showed a trend of lower survival rate in the remaining six pediatric tumors, particularly in cases of NB and brain tumors.

The analysis showed a trend of increasing knowledge index scores with higher educational qualifications.

MVs showed a trend towards extending lifespan in the Caenorhabditis elegans in vivo model upon infection with Pseudomonas aeruginosa .

The conversion from cyclosporin to tacrolimus generally showed a trend toward reduced or stable UA levels during follow-up, although two studies did not find a difference, and one study indicated a detrimental effect on UA after conversion.

Two patients showed a trend in increasing the percentage of fats.

The mean age at diagnosis was comparable between groups but showed a trend toward younger age in the UNPMCC group (67.8 years) compared with patients with known primary MCC (71.2 years).

Although higher haemoglobin levels showed a trend towards a lower OR, statistical significance was not achieved for the 90-day outcome (OR, 0.89; 95% CI, 0.78–1.03 for 90 days; OR, 0.88; 95% CI, 0.79–0.99 for 180 days).